PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MNTS vs. CORZZ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MNTS and CORZZ is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.1

Performance

MNTS vs. CORZZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Momentus Inc. (MNTS) and Core Scientific Inc. Tranche 2 Warrants (CORZZ). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%1,000.00%NovemberDecember2025FebruaryMarchApril
-82.65%
301.76%
MNTS
CORZZ

Key characteristics

Sharpe Ratio

MNTS:

-0.29

CORZZ:

3.95

Sortino Ratio

MNTS:

0.82

CORZZ:

3.43

Omega Ratio

MNTS:

1.09

CORZZ:

1.44

Calmar Ratio

MNTS:

-0.66

CORZZ:

6.68

Martin Ratio

MNTS:

-1.26

CORZZ:

16.89

Ulcer Index

MNTS:

52.11%

CORZZ:

25.80%

Daily Std Dev

MNTS:

227.75%

CORZZ:

110.20%

Max Drawdown

MNTS:

-99.99%

CORZZ:

-65.20%

Current Drawdown

MNTS:

-99.99%

CORZZ:

-63.77%

Fundamentals

PS Ratio

MNTS:

4.07

CORZZ:

0.00

PB Ratio

MNTS:

3.92

CORZZ:

0.00

Total Revenue (TTM)

MNTS:

$1.70M

CORZZ:

$331.38M

Gross Profit (TTM)

MNTS:

$1.29M

CORZZ:

$43.42M

EBITDA (TTM)

MNTS:

-$31.72M

CORZZ:

-$1.41B

Returns By Period

In the year-to-date period, MNTS achieves a -77.30% return, which is significantly lower than CORZZ's -53.00% return.


MNTS

YTD

-77.30%

1M

-6.74%

6M

-80.92%

1Y

-65.16%

5Y*

-80.90%

10Y*

N/A

CORZZ

YTD

-53.00%

1M

-22.38%

6M

-48.48%

1Y

306.79%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MNTS vs. CORZZ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MNTS
The Risk-Adjusted Performance Rank of MNTS is 3939
Overall Rank
The Sharpe Ratio Rank of MNTS is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of MNTS is 6363
Sortino Ratio Rank
The Omega Ratio Rank of MNTS is 5959
Omega Ratio Rank
The Calmar Ratio Rank of MNTS is 1313
Calmar Ratio Rank
The Martin Ratio Rank of MNTS is 2020
Martin Ratio Rank

CORZZ
The Risk-Adjusted Performance Rank of CORZZ is 9898
Overall Rank
The Sharpe Ratio Rank of CORZZ is 100100
Sharpe Ratio Rank
The Sortino Ratio Rank of CORZZ is 9797
Sortino Ratio Rank
The Omega Ratio Rank of CORZZ is 9595
Omega Ratio Rank
The Calmar Ratio Rank of CORZZ is 100100
Calmar Ratio Rank
The Martin Ratio Rank of CORZZ is 9898
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MNTS vs. CORZZ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Momentus Inc. (MNTS) and Core Scientific Inc. Tranche 2 Warrants (CORZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MNTS, currently valued at -0.29, compared to the broader market-2.00-1.000.001.002.003.00
MNTS: -0.29
CORZZ: 3.95
The chart of Sortino ratio for MNTS, currently valued at 0.82, compared to the broader market-6.00-4.00-2.000.002.004.00
MNTS: 0.82
CORZZ: 3.43
The chart of Omega ratio for MNTS, currently valued at 1.09, compared to the broader market0.501.001.502.00
MNTS: 1.09
CORZZ: 1.44
The chart of Calmar ratio for MNTS, currently valued at -0.74, compared to the broader market0.001.002.003.004.00
MNTS: -0.74
CORZZ: 6.68
The chart of Martin ratio for MNTS, currently valued at -1.26, compared to the broader market-5.000.005.0010.0015.0020.00
MNTS: -1.26
CORZZ: 16.89

The current MNTS Sharpe Ratio is -0.29, which is lower than the CORZZ Sharpe Ratio of 3.95. The chart below compares the historical Sharpe Ratios of MNTS and CORZZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00Feb 02Feb 09Feb 16Feb 23Mar 02Mar 09Mar 16Mar 23Mar 30Apr 06Apr 13
-0.29
3.95
MNTS
CORZZ

Dividends

MNTS vs. CORZZ - Dividend Comparison

Neither MNTS nor CORZZ has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MNTS vs. CORZZ - Drawdown Comparison

The maximum MNTS drawdown since its inception was -99.99%, which is greater than CORZZ's maximum drawdown of -65.20%. Use the drawdown chart below to compare losses from any high point for MNTS and CORZZ. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-87.87%
-63.77%
MNTS
CORZZ

Volatility

MNTS vs. CORZZ - Volatility Comparison

The current volatility for Momentus Inc. (MNTS) is 27.18%, while Core Scientific Inc. Tranche 2 Warrants (CORZZ) has a volatility of 39.35%. This indicates that MNTS experiences smaller price fluctuations and is considered to be less risky than CORZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%100.00%120.00%NovemberDecember2025FebruaryMarchApril
27.18%
39.35%
MNTS
CORZZ

Financials

MNTS vs. CORZZ - Financials Comparison

This section allows you to compare key financial metrics between Momentus Inc. and Core Scientific Inc. Tranche 2 Warrants. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab